Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Langenbeck's Archives of Surgery
Erschienen in: Langenbeck's Archives of Surgery 3/2008

01.05.2008 | Current Concepts in Endocrine Surgery

Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach

verfasst von: Antonio Sitges-Serra, Prieto Rosa, Mónica Valero, Estela Membrilla, Joan J. Sancho

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Sporadic primary hyperparathyroidism is due to single adenoma in over 90–95% of instances. Careful medical history and precise preoperative identification of the enlarged gland by parathyroid Tc-mibi scintigraphy and neck ultrasound allow selecting patients for minimally invasive parathyroidectomy, a focused intervention with minimal skin opening and tissue dissection. Small (<300 mg) adenomas continue to challenge preoperative imaging, and most of them will still require a bilateral exploration.

Conclusion

Surgery should never be indicated on the basis of positive or negative preoperative localization studies. Intraoperative quick parathyroid hormone measurements seem particularly helpful for cases with equivocal localization studies. The best minimal access approach is still a matter of debate, and options include small central incision, video-assisted parathyroidectomy, minimal lateral open approach, and purely endoscopic access via lateral approach. Radioguided surgery does not seem to have a role in routine cases but may be useful to find adenomas during reintervention on scarred difficult surgical fields.
Literatur
1.
Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551PubMedCrossRef
2.
Russell CF, Dolan SJ, Laird JD (2006) Randomized clinical trial comparing scan-directed unilateral versus bilateral cervical exploration for primary hyperparathyroidism due to solitary adenoma. Br J Surg 93:418–421PubMedCrossRef
3.
Tiblin S, Bondeson AG, Ljunberg O (1982) Unilateral parathyroidectomy due to single adenoma. Ann Surg 195:245–251CrossRef
4.
Russell CF, Laird JD, Ferguson WR (1990) Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach. World J Surg 14:406–409PubMedCrossRef
5.
Sackett WR, Barraclough B, Reeve TS, Delbridge LW (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137:1055–1059PubMedCrossRef
6.
Grant CS, Thompson G, Farley D, van Heerden J (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478PubMedCrossRef
7.
Schachter PP, Issa N, Shimonov M, Czerniak A, Lorberboym M (2004) Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg 139:433–437PubMedCrossRef
8.
O’Doherty MJ, Kettle AG (2003) Parathyroid imaging: preoperative localization. Nucl Med Comm 24:125–31CrossRef
9.
Civelek AC, Ozalp E, Donovan P, Udelsman R (2002) Prospective evaluation of delayed technetium-99 m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery 131:149–157PubMedCrossRef
10.
Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880PubMedCrossRef
11.
Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD Jr. (2006) Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg 141:381–384PubMedCrossRef
12.
Krausz Y, Lebensart PD, Klein M, Weininger J, Blachar A, Chisin R, Shiloni E (2000) Preoperative localization of parathyroid adenoma in patients with concomitant thyroid nodular disease. World J Surg 24:1573–1578PubMedCrossRef
13.
Rink T, Schroth HJ, Holle LH, Garth LH (2002) Limited sensitivity of parathyroid imaging with 99mTc-sestamibi/123I subtraction in an endemic goiter area. J Nucl Med 43:1175–1180PubMed
14.
Prager G, Czerny C, Ofluoglu S, Kurtaran A, Passler C, Kaczirek K, Scheuba C, Niederle B (2003) Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region. J Am Coll Surg 196:541–548PubMedCrossRef
15.
Pattou F, Huglo D, Proye C (1998) Radionuclide scanning in parathyroid diseases. Br J Surg 85:1605–1616PubMedCrossRef
16.
Perrier ND, Ituarte PH, Morita E, Hamill T, Gielow R, Duh QY, Clark OH (2002) Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 87:1024–1029PubMedCrossRef
17.
Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746PubMedCrossRef
18.
Piñero A, Rodriguez JM, Martinez-Barba E, Canteras M, Sitges-Serra A, Parrilla P (2003) Tc99 m-sestamibi scintigraphy and cell proliferation in primary hyperparathyroidism: a causal or casual relationship. Surgery 134:41–44PubMedCrossRef
19.
Pons F, Torregrosa JV, Fuster D (2003) Biological factors influencing parathyroid localization. Nucl Med Commun 24:121–124PubMedCrossRef
20.
Biertho LD, Kim C, Wu HS, Unger P, Inabnet WB (2004) Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 199:229–233PubMedCrossRef
21.
Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP (2006) Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg 30:697–704PubMedCrossRef
22.
Slitt GT, Lavery H, Morgan A, Bernstein B, Slavin J, Karimeddini MK, Kozol RA (2005) Hyperparathyroidism but a negative sestamibi scan: a clinical dilemma. Am J Surg 190:708–712PubMedCrossRef
23.
Lowney JK, Weber B, Johnson S, Doherty GM (2000) Minimal incision parathyroidectomy: cure, cosmesis, and cost. World J Surg 24:1442–1445PubMedCrossRef
24.
Brunaud L, Zarnegar R, Wada N, Ituarte P, Clark OH, Duh QY (2003) Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive. Arch Surg 138:1140–1143PubMedCrossRef
25.
Carter AB, Howanitz PJ (2003) Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 127:1424–1442PubMed
26.
Stalberg P, Sidhu S, Sywak M, Robinson B, Wilkinson M, Delbridge L (2006) Intraoperative Parathyroid hormone measurement during minimally invasive parathyroidectomy: does it “value-add” to decision-making. J Am Coll Surg 203:1–6PubMedCrossRef
27.
Miura D, Wada N, Arici C, Morita E, Duh QY, Clark OH (2002) Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy. World J Surg 26:926–930PubMedCrossRef
28.
Carneiro-Pla DM, Solorzano CC, Irvin GL 3rd (2006) Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg 202:715–722PubMedCrossRef
29.
Chen H, Pruhs Z, Starling JR, Mack E (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–587PubMedCrossRef
30.
Goldstein RE, Carter WM, Fleming M, Bumpous J, Lentsch E, Rice M, Flynn M (2006) Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Arch Surg 141:552–559PubMedCrossRef
31.
Zettinig G, Kurtaran A, Prager G, Kaserer K, Dudczak R, Niederle B (2002) ‘Suppressed’ double adenoma—a rare pitfall in minimally invasive parathyroidectomy. Horm Res 57:57–60PubMedCrossRef
32.
Westerdahl J, Bergenfelz A (2006) Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels. Unobserved multiple endocrine neoplasia as an explanation.. Arch Surg 141:589–594PubMedCrossRef
33.
Gauger PG, Agarwal G, England BG, Delbridge LW, Matz KA, Wilkinson M, Robinson BG, Thompson NW (2003) Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery 130:1005–1010CrossRef
34.
Milas M, Wagner K, Easley KA, Siperstein A, Weber CJ (2003) Double adenomas revisited: nonuniform distribution favors enlarged superior parathyroids (fourth pouch disease). Surgery 134:995–1003PubMedCrossRef
35.
Haciyanli M, Lal G, Morita E, Duh QY, Kebebew E, Clark OH (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739–746PubMedCrossRef
36.
Jaskowiak NT, Sugg SL, Helke J, Koka MR, Kaplan EL (2002) Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137:659–668PubMedCrossRef
37.
Horanyi J, Duffek L, Szlavik R, Darvas K, Lakatos P, Toth M, Racz K (2003) Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels. J Endocrinol Invest 6:1095–1099
38.
Irvin GL 3rd, Solorzano CC, Carneiro DM (2004) Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 28:1287–1292PubMedCrossRef
39.
Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186–190PubMedCrossRef
40.
Gurnell EM, Thomas SK, McFarlane I, Munday I, Balan KK, Berman L, Chatterjee VK, Wishart GC (2004) Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedure. Br J Surg 91:78–82PubMedCrossRef
41.
Duh QY (2003) Presidential address: minimally invasive endocrine surgery—standard of treatment or hype. Surgery 134:849–857PubMedCrossRef
42.
Miccoli P, Berti P, Materazzi G, Massi M, Picone A, Minuto MN (2004) Results of video-assisted parathyroidectomy: single institution’s six-year experience. World J Surg 28:1216–1218PubMedCrossRef
43.
Barczynski M, Cichon S, Konturek A, Cichon W (2006) Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 30:721–731PubMedCrossRef
44.
Henry JF, Sebag F, Tamagnini P, Forman C, Silaghi H (2004) Endoscopic parathyroid surgery: results of 365 consecutive procedures. World J Surg 28:1219–1223PubMedCrossRef
45.
Udelsman R, Donovan PI (2004) Open minimally invasive parathyroid surgery. World J Surg 28:1224–1226PubMedCrossRef
46.
Ishibashi M, Nishida H, Hiromatsu Y, Kojima K, Tabuchi E, Hayabuchi N (1998) Comparison of technetium-99 m-MIBI, technetium-99 m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med 39:320–324PubMed
47.
Murphy C, Norman J (1999) The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 126:1023–1028PubMedCrossRef
48.
Rubello D, Giannini S, Martini C, Piotto A, Rampin L, Fanti S (2006) Minimally invasive radio-guided parathyroidectomy. Biomed Pharmacother 260:134–138CrossRef
49.
Bonjer HJ, Bruining HA, Pols HA, de Herder WW, Proye CA, Carnaille BM, Mohamedammin DS, Steyerberg EW, Breeman WA, Krening EP (1998) 2-Methoxyisobutylisonitrile probe during parathyroid surgery: tool or gadget. World J Surg 22:507–511PubMedCrossRef
50.
Dackiw AP, Sussman JJ, Fritsche HA Jr, Delpassand ES, Stanford P, Hoff A (2000) Relative contributions of technetium Tc 99 m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550–555PubMedCrossRef
51.
Costello D, Norman J (1999) Minimally invasive radioguided parathyroidectomy. Surg Oncol Clin N Am 8:555–564PubMed
52.
Burkey SH, Van Heerden JA, Farley DR, Thompson GB, Grant CS, Curlee KJ (2002) Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism. World J Surg 26:914–920PubMedCrossRef
53.
Inabnet WB 3rd, Kim CK, Haber RS, Lopchinsky RA (2002) Radioguidance is not necessary during parathyroidectomy. Arch Surg 137:967–970PubMedCrossRef
Metadaten
Titel
Surgery for sporadic primary hyperparathyroidism: controversies and evidence-based approach
verfasst von
Antonio Sitges-Serra
Prieto Rosa
Mónica Valero
Estela Membrilla
Joan J. Sancho
Publikationsdatum
01.05.2008
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 3/2008
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-008-0283-9

Weitere Artikel der Ausgabe 3/2008

Langenbeck's Archives of Surgery 3/2008 Zur Ausgabe

Original Article

Lactate modulates gene expression in human mesenchymal stem cells

Current Concept in Clinical Surgery

Early enteral nutrition in acute pancreatitis—benefits and limitations

Original Article

Use of Erythropoietin as adjuvant therapy in nerve reconstruction

Abstracts

3rd Biennial Congress of the European Society of Endocrine Surgeons, Barcelona, 24–26 April 2008

Original Article

Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients

Original Article

Prolene–Monocryl-composite meshes do not increase microvascular Staphylococcus aureus adherence and do not sensitize for leukocytic inflammation

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.